seribantumab
elevation oncology
['crestone', 'seribantumab', 'kare']
#cedarssinaicancer at #aacr23. dr. karen reckamp is co-author on crestone: a phase 2 study of seribantumab in adult patients with neuregulin-1 fusion positive locally advanced or metastatic solid #tumors presented at 6:00am. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.